Protein tyrosine phosphatase non-receptor type 2 ( PTPN2 ) is a tyrosine phosphatase involved in T cell receptor signal ...
Reduced diffusing capacity of the lungs for carbon monoxide (DLco) reflects microvasculopathy in chronic thromboembolic ...
Correspondence to Professor Talat Islam, Department of Population and Public Health Science, University of Southern California, Los Angeles, CA-90033, USA; islam{at}usc.edu Rationale Despite high ...
Correspondence to Professor Claire L Shovlin, Professor of Practice (Clinical and Molecular Medicine), NHLI Vascular Science, Imperial College London, Imperial Centre for Translational and ...
5 Asthma UK Centre for Applied Research, Blizard Institute, Queen Mary University of London, London, UK Correspondence to Professor Adrian R Martineau, The Centre for Primary Care and Public Health, ...
In a recent case (00/TLQ/1284) in the Queen's Bench Division of the High Court in England, a widow sued on behalf of her husband who had died at the age of 60 of mesothelioma. Unusually for such cases ...
Background Infections are considered as leading causes of acute exacerbations of chronic obstructive pulmonary disease (COPD). Non-infectious risk factors such as short-term air pollution exposure may ...
Department of Cardiology and Respiratory Medicine, Hvidovre Hospital and Faculty of Health Sciences, University of Copenhagen, Hvidovre Hospital, Hvidovre, Denmark Background: Little is known about ...
Background: Non-invasive ventilation is first-line treatment for patients with acutely decompensated chronic obstructive pulmonary disease (COPD), but endotracheal intubation, involving admission to ...
Introduction Vitamin D deficiency has been associated with many chronic illnesses, but little is known about its relationship with chronic obstructive pulmonary disease (COPD). Objectives Serum ...
Correspondence to Robert A Stockley, Lung Investigation Unit, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK; rob.stockley{at}uhb.nhs.uk Chronic obstructive pulmonary disease (COPD) is ...
Correspondence to Professor Ian Hall, Division of Therapeutics, Queen's Medical Centre, Nottingham NG7 2UH, UK; ian.hall{at}nottingham.ac.uk In July 2021, the UK Office of Life Sciences (OLS)1 ...